Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Crystal Flush is a consumer healthcare company specializing in the treatment of fungal nail infections, specifically onychomycosis. The company provides a comprehensive multi-step system designed to treat fungus both topically and internally. Its primary topical treatment contains tolnaftate, an FDA-approved antifungal agent, while its Balance supplement aims to address internal fungal overgrowth using botanical extracts and probiotics. Crystal Flush positions its products as a more effective alternative to standard over-the-counter topical treatments by targeting the systemic nature of fungal infections. The company operates primarily through direct-to-consumer e-commerce channels and markets its products as being developed in consultation with medical professionals.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Crystal Flush.